Arcus Biosciences Inc
NYSE:RCUS
Arcus Biosciences Inc
NYSE:RCUS
Price:
24.56
USD
4.82%
Market Cap:
$3B
Income Statement
Earnings Waterfall
Arcus Biosciences Inc
Arcus Biosciences Inc
Income Statement
Arcus Biosciences Inc
Arcus Biosciences Inc
Currency: USD
| Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||
| Revenue |
1
N/A
|
3
+100%
|
4
+46%
|
8
+100%
|
8
+2%
|
9
+7%
|
10
+6%
|
7
-26%
|
15
+114%
|
15
+1%
|
15
N/A
|
78
+413%
|
78
-1%
|
85
+10%
|
93
+9%
|
38
-59%
|
383
+908%
|
392
+2%
|
409
+4%
|
433
+6%
|
112
-74%
|
119
+6%
|
121
+2%
|
120
-1%
|
117
-2%
|
237
+103%
|
247
+4%
|
263
+6%
|
258
-2%
|
141
-45%
|
262
+86%
|
240
-8%
|
247
+3%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||
| Operating Expenses |
(55)
|
(62)
|
(70)
|
(63)
|
(63)
|
(69)
|
(83)
|
(91)
|
(104)
|
(113)
|
(130)
|
(168)
|
(202)
|
(254)
|
(292)
|
(317)
|
(329)
|
(332)
|
(342)
|
(357)
|
(392)
|
(418)
|
(434)
|
(443)
|
(457)
|
(487)
|
(520)
|
(561)
|
(568)
|
(577)
|
(600)
|
(615)
|
(633)
|
|
| Selling, General & Administrative |
(8)
|
(9)
|
(11)
|
(12)
|
(14)
|
(16)
|
(18)
|
(22)
|
(25)
|
(27)
|
(33)
|
(36)
|
(42)
|
(51)
|
(57)
|
(62)
|
(72)
|
(80)
|
(89)
|
(99)
|
(104)
|
(110)
|
(112)
|
(116)
|
(117)
|
(119)
|
(121)
|
(121)
|
(120)
|
(116)
|
(115)
|
(112)
|
(110)
|
|
| Research & Development |
(47)
|
(53)
|
(59)
|
(50)
|
(50)
|
(54)
|
(65)
|
(69)
|
(79)
|
(86)
|
(97)
|
(131)
|
(159)
|
(203)
|
(236)
|
(255)
|
(256)
|
(251)
|
(252)
|
(258)
|
(288)
|
(308)
|
(322)
|
(327)
|
(340)
|
(368)
|
(399)
|
(440)
|
(448)
|
(461)
|
(485)
|
(503)
|
(523)
|
|
| Operating Income |
(53)
N/A
|
(59)
-11%
|
(66)
-10%
|
(55)
+17%
|
(55)
-1%
|
(60)
-10%
|
(74)
-22%
|
(85)
-15%
|
(89)
-5%
|
(98)
-11%
|
(115)
-16%
|
(90)
+22%
|
(124)
-38%
|
(169)
-36%
|
(199)
-18%
|
(279)
-40%
|
54
N/A
|
60
+11%
|
67
+12%
|
76
+13%
|
(280)
N/A
|
(299)
-7%
|
(313)
-5%
|
(323)
-3%
|
(340)
-5%
|
(250)
+26%
|
(273)
-9%
|
(298)
-9%
|
(310)
-4%
|
(436)
-41%
|
(338)
+22%
|
(375)
-11%
|
(386)
-3%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
1
|
3
|
4
|
5
|
6
|
5
|
4
|
4
|
4
|
3
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
4
|
9
|
16
|
24
|
31
|
38
|
41
|
45
|
49
|
51
|
52
|
50
|
45
|
38
|
33
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(20)
|
(20)
|
(20)
|
(20)
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(4)
|
(4)
|
(6)
|
(3)
|
0
|
|
| Pre-Tax Income |
(53)
N/A
|
(59)
-11%
|
(63)
-7%
|
(51)
+20%
|
(50)
+2%
|
(54)
-9%
|
(69)
-27%
|
(81)
-17%
|
(85)
-5%
|
(95)
-12%
|
(112)
-18%
|
(88)
+22%
|
(123)
-40%
|
(168)
-37%
|
(199)
-18%
|
(279)
-40%
|
55
N/A
|
60
+10%
|
70
+16%
|
83
+19%
|
(266)
N/A
|
(277)
-4%
|
(284)
-3%
|
(289)
-1%
|
(301)
-4%
|
(227)
+25%
|
(246)
-8%
|
(269)
-9%
|
(282)
-5%
|
(390)
-38%
|
(297)
+24%
|
(340)
-14%
|
(353)
-4%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(3)
|
(3)
|
(3)
|
(1)
|
(2)
|
(3)
|
(5)
|
(6)
|
(4)
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
|
| Income from Continuing Operations |
(53)
|
(59)
|
(63)
|
(51)
|
(50)
|
(54)
|
(69)
|
(81)
|
(85)
|
(95)
|
(112)
|
(88)
|
(123)
|
(168)
|
(199)
|
(279)
|
53
|
57
|
67
|
80
|
(267)
|
(279)
|
(287)
|
(294)
|
(307)
|
(231)
|
(249)
|
(270)
|
(283)
|
(391)
|
(298)
|
(341)
|
(353)
|
|
| Net Income (Common) |
(53)
N/A
|
(59)
-11%
|
(63)
-7%
|
(51)
+20%
|
(50)
+2%
|
(54)
-9%
|
(69)
-27%
|
(81)
-17%
|
(85)
-5%
|
(95)
-12%
|
(112)
-18%
|
(88)
+22%
|
(123)
-40%
|
(168)
-37%
|
(199)
-18%
|
(279)
-40%
|
53
N/A
|
57
+9%
|
67
+16%
|
80
+20%
|
(267)
N/A
|
(279)
-4%
|
(287)
-3%
|
(294)
-2%
|
(307)
-5%
|
(231)
+25%
|
(249)
-8%
|
(270)
-8%
|
(283)
-5%
|
(391)
-38%
|
(298)
+24%
|
(341)
-14%
|
(353)
-4%
|
|
| EPS (Diluted) |
-1.27
N/A
|
-1.32
-4%
|
-1.49
-13%
|
-1.18
+21%
|
-1.43
-21%
|
-1.24
+13%
|
-1.57
-27%
|
-1.83
-17%
|
-1.93
-5%
|
-2.16
-12%
|
-2.3
-6%
|
-1.34
+42%
|
-2.24
-67%
|
-2.5
-12%
|
-2.85
-14%
|
-3.97
-39%
|
0.71
N/A
|
0.8
+13%
|
0.93
+16%
|
1.1
+18%
|
-3.71
N/A
|
-3.82
-3%
|
-3.92
-3%
|
-3.93
0%
|
-4.15
-6%
|
-2.68
+35%
|
-2.73
-2%
|
-2.96
-8%
|
-3.14
-6%
|
-3.97
-26%
|
-2.79
+30%
|
-3.2
-15%
|
-3.29
-3%
|
|
Switch to:
Switch to:
See Also
Discover More
